1 Product identity
Ingredient risk
Contains restricted ingredients

NooCamilon Picamilon 50

BrandLifeLinkOther Combinations Capsule 3 ingredients 1 banned DSLD #11772
Net contents: 120 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-08-24
2 Ingredients (3)
IngredientGroupSafety
PicamilonPicamilonBanned in ≥1 country
Microcrystalline CelluloseCellulose
GelatinGelatin
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Picamilon  🇺🇸 — 2015: Not a dietary ingredient. Products must be removed.
3 Safety cross-reference
Picamilon — Banned in ≥1 country
⚠ Synthetic compound: niacin + GABA
⚠ Crosses blood-brain barrier
4 Label claims
• All Other
5 Data source
DSLD ID11772
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-08-24
6 More from LifeLink
View LifeLink Safety Scorecard → 76 products
5-HTP 5-Hydroxy-L-Trytophan 1005-HTP 5-Hydroxy-L-Trytophan 1005-HTP 5-Hydroxy-L-Trytophan 255-HTP 5-Hydroxy-L-Trytophan 505-HTP 5-Hydroxy-L-Trytophan 50ALC Acetyl L-Carnitine 500
7 Cite this page
Vancouver
Pkhakadze G. NooCamilon Picamilon 50 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 31]. Available from: https://supplement.ge/products/noocamilon-picamilon-50-11772/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network